Showing results (21-30 of 24) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Advances in Experimental Medicine and Biology|September 29, 1999
CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patientsBaryshnikov AYu, E R Polosukhina, N N Tupitsin, et al.Bulletin of Experimental Biology and Medicine|November 30, 2018
Tumor-Infiltrating Lymphocytes in Breast Cancer. Association with Clinical and Pathological ParametersT N Zabotina, O V Korotkova, A I Chertkova, et al.Terapevticheskii Arkhiv|October 6, 2000
[Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy]A K Golenkov, E V Trifonova, E V Kataeva, et al.Terapevticheskii Arkhiv|September 22, 1998
[An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia]E R Polosukhina, S V Kuznetsov, N P Logcheva, et al.Pageof 3